Geisinger and Tempus Announce Collaboration to Develop Cardiology Diagnostic and Prognostic Tools Using Artificial Intelligence
September 17, 2019
September 17, 2019
DANVILLE, Pennsylvania, Sept. 17 -- Geisinger Health issued the following news release:
Geisinger announced today a new multi-year partnership with Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The collaboration aims to use the power of machine learning and artificial intelligence to build new precision medicine tools for cardiology that will enable the prediction of dangerous cardiac events and . . .
Geisinger announced today a new multi-year partnership with Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The collaboration aims to use the power of machine learning and artificial intelligence to build new precision medicine tools for cardiology that will enable the prediction of dangerous cardiac events and . . .